GUGGENHEIM CAPITAL LLC - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 176 filers reported holding ACORDA THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q1 2018$1,966,000
-0.5%
83,173
-9.7%
0.01%0.0%
Q4 2017$1,976,000
-28.6%
92,109
-21.3%
0.01%
-28.6%
Q3 2017$2,769,000
+34.9%
117,110
+12.4%
0.01%
+40.0%
Q2 2017$2,052,000
+15.3%
104,183
+22.9%
0.01%0.0%
Q1 2017$1,780,000
+3.9%
84,751
-7.0%
0.01%0.0%
Q4 2016$1,713,000
-28.4%
91,107
-20.4%
0.01%
-28.6%
Q3 2016$2,391,000
-21.8%
114,500
-4.4%
0.01%
-30.0%
Q2 2016$3,056,000
-7.6%
119,818
-4.2%
0.01%0.0%
Q1 2016$3,307,000
-45.8%
125,025
-12.4%
0.01%
-44.4%
Q4 2015$6,107,000
+19.8%
142,754
-25.8%
0.02%
+12.5%
Q3 2015$5,098,000
-23.5%
192,307
-3.9%
0.02%0.0%
Q2 2015$6,668,000
+12.6%
200,045
+12.4%
0.02%
+14.3%
Q1 2015$5,923,000
+27.5%
177,985
+56.7%
0.01%
+16.7%
Q4 2014$4,644,000
-4.5%
113,612
-20.9%
0.01%0.0%
Q3 2014$4,863,000
+12.1%
143,559
+11.6%
0.01%
+9.1%
Q2 2014$4,338,000
-23.1%
128,682
-13.5%
0.01%
-31.2%
Q1 2014$5,638,000
+13.9%
148,721
-12.2%
0.02%
+6.7%
Q4 2013$4,948,000
+4.3%
169,471
+22.4%
0.02%
-11.8%
Q3 2013$4,745,000
+30.9%
138,417
+25.9%
0.02%
+13.3%
Q2 2013$3,626,000109,9220.02%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q3 2014
NameSharesValueWeighting ↓
Ghost Tree Capital, LLC 325,000$8,289,0002.39%
ARMISTICE CAPITAL, LLC 232,000$5,917,0002.25%
SENZAR ASSET MANAGEMENT, LLC 358,191$9,135,662,0001.99%
SCOPIA CAPITAL MANAGEMENT LP 3,171,229$80,882,0001.67%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,029,410$26,255,0001.03%
Baker Brothers Advisors 3,661,082$93,376,0000.98%
ARBOR CAPITAL MANAGEMENT LLC 58,783$1,499,0000.79%
Spark Investment Management LLC 292,400$7,457,0000.70%
SPHERA FUNDS MANAGEMENT LTD. 98,000$2,499,0000.65%
Virtus ETF Advisers LLC 21,130$539,0000.40%
View complete list of ACORDA THERAPEUTICS INC shareholders